A new report from the National Academies of Sciences, Engineering, and Medicine recommends two frameworks that medical professional societies, health care organizations, and state, national and local agencies could use to develop clinical practice guidelines for prescribing opioids to manage acute pain. Requested by the Food and Drug Administration, the report also identifies surgical procedures and acute medical conditions for which evidence-based guidelines would be desirable. Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, said the agency will consider the recommendations as it develops evidence-based prescribing guidelines for treating acute pain in therapeutic areas for which guidelines do not exist.

Related News Articles

Headline
“Safety Speaks” is a new Advancing Health series where hospital and health system leaders share successes from their organizations’ patient safety efforts. In…
Headline
A new issue brief from AHA’s Hospitals Against Violence initiative offers proven strategies and action steps to help hospitals and health systems’ violence…
Headline
AHA urged leaders of the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, and Education to give favorable funding…
Headline
The Department of Justice May 9 announced the formation of a task force focusing on competition concerns in health care. The unit, the Task Force on Health…
Headline
The Food and Drug Administration April 29 issued a final rule that would phase out its general enforcement discretion approach for most laboratory developed…
Headline
Commenting April 12 on a proposed rule to strengthen oversight of accrediting organizations, AHA told the Centers for Medicare & Medicaid Services it…